Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS AND BALANCES

v3.8.0.1
RELATED PARTY TRANSACTIONS AND BALANCES
9 Months Ended
Dec. 31, 2017
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
9.
RELATED PARTY TRANSACTIONS AND BALANCES
 
a) Due from related parties
 
As of December 31, 2017, there was an outstanding loan to the Chief Technology Officer and director of the Company for $19,374 (March 31, 2017 - $18,731). The loan has an interest rate of 1% based on the Canada Revenue Agency’s prescribed rate for such advances and is denominated in Canadian dollars. During the nine months ended December 31, 2017, the Company accrued interest receivable in the amount of ($649) (March 31, 2017 - $707). The remaining fluctuation in the balance from the prior year is due to changes in foreign exchange.
 
b) Accounts payable and accrued liabilities
 
As at December 31, 2017, $89,141 (March 31, 2017 - $Nil) was owing to the CEO of the Company; $47,307 (March 31, 2017 - $Nil to the former CTO) was owing to the Chief Technology Officer; $16,592 (March 31, 2017 – $Nil) was owing to the Chief Financial Officer, $97,500 (March 31, 2017 – $97,500) was owing to the Chief Commercialization Officer, and $639,375 (March 31, 2017 – $4,135) was owing to the former CEO and current Chairman of the Board, all related to business, compensation and severance expenses, all of which are included in accounts payable or accrued liabilities.
 
In connection with the acquisition of IMT, the Company acquired a license agreement dated June 8, 2009, pursuant to which the Company pays the licensors an aggregate royalty of 1% of sales based on patent #8,613,6391. No sales were made, as the technology under this patent has not been commercialized. One of the licensors is a founder of IMT and a former officer and director of the Company.
 
As at the effective date of the merger pursuant to the Merger Agreement, a former officer and director received an aggregate of 5,190,376 shares of the Company in return for his ownership of IMT securities, in addition to his IMT options which were as of the effective date of the merger exercisable for an aggregate of 360,231 shares of common stock of the Company.